Synthesis and Cytotoxic Activity of Ethyl 2-Amino-1-Benzamido-4-Oxo-5-(2-Oxo-2-Arylethylidene)- 4,5-Dihydro-1H-Pyrrole-3-Carboxylates


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Recyclization of 5-aryl-2,3-dihydro-2-furandione 3-benzoylhydrazones (I) induced by cyanoacetic ester produced ethyl 2-amino-1-benzamido-4-oxo-5-(2-oxo-2-arylethylidene)-4,5-dihydro-1H-pyrrole-3-carboxylates (IIa-g). The biological activity of the synthesized compounds, which possessed low toxicities, was investigated. Ethyl 2-amino-1-benzamido-5-[2-(4-chlorophenyl)-2-oxoethylidene]-4-oxo-4,5-dihydro-1H-pyrrole-3-carboxylate (IIf) and the 5-[2-(3,4-dimethoxyphenyl)-2-oxoethylidene] analog (IIc) exhibited the greatest cytotoxicities against several connective-tissue tumor cell lines, namely, gastrointestinal stromal tumors (GISTs), osteosarcoma U2OS, and leiomyosarcoma SK-LMS-1. Ethyl 2-amino-1-benzamido-4-oxo-5-[2-oxo-2-(p-tolyl)ethylidene]-4,5-dihydro-1H-pyrrole-3-carboxylate (IIa) suppressed significantly tumor growth of GIST, LMS, and OS cell lines. Its activity against GIST cells at 10 μM was comparable with that of imatinib (1 μM) and, at lower concentrations (2.5 and 5 μM), with those of doxorubicin (0.25 μg/mL) and etoposide (40 μM), and exceeded significantly those of taxol (1 μM) and hydroxyurea (1 mM). The cytotoxicities of most of the studied compounds at 10 μM against SK-LMS-1 and U2OS cells in vitro were significantly greater than all reference drugs (doxorubicin, taxol, etoposide, etc.).

Sobre autores

S. Zykova

Perm Federal Penal Service Institute

Autor responsável pela correspondência
Email: zykova.sv@rambler.ru
Rússia, 125 Karpinskogo St., Perm, 614012

A. Galembikova

Kazan State Medical University

Email: zykova.sv@rambler.ru
Rússia, 49 Butlerova St., Kazan, Tatarstan, 420012

B. Ramazanov

Kazan State Medical University

Email: zykova.sv@rambler.ru
Rússia, 49 Butlerova St., Kazan, Tatarstan, 420012

T. Odegova

Perm State Pharmaceutical Academy

Email: zykova.sv@rambler.ru
Rússia, 2 Polevaya St., Perm, 614009

N. Igidov

Perm State Pharmaceutical Academy

Email: zykova.sv@rambler.ru
Rússia, 2 Polevaya St., Perm, 614009

M. Kiselev

Perm State Pharmaceutical Academy

Email: zykova.sv@rambler.ru
Rússia, 2 Polevaya St., Perm, 614009

S. Boichuk

Kazan State Medical University

Email: zykova.sv@rambler.ru
Rússia, 49 Butlerova St., Kazan, Tatarstan, 420012

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Springer Science+Business Media New York, 2016